During the past decade, Southampton National Institute for Health Research, Wellcome Trust Clinical Research Facility conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 1 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Southampton National Institute for Health Research, Wellcome Trust Clinical Research Facility" #1 collaborator was "Gilead Sciences" with 3 trials as a collaborator, "University Hospital Southampton NHS Foundation Trust" with 3 trials as a collaborator and "Galapagos NV" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Southampton National Institute for Health Research, Wellcome Trust Clinical Research Facility" are "Meningitis, Bacterial" (3 trials), "Crohn's Disease" (2 trials), "Influenza" (2 trials), "Ulcerative Colitis" (2 trials) and "Neisseria Infection" (1 trials). Many other conditions were trialed in "Southampton National Institute for Health Research, Wellcome Trust Clinical Research Facility" in a lesser frequency.

Most popular intervention types in "Southampton National Institute for Health Research, Wellcome Trust Clinical Research Facility" are "Drug" (5 trials), "Biological" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Filgotinib" (4 trials), "N. lactamica" (2 trials), "Placebo" (2 trials), "Baxter Novel Influenza A H1N1 Whole Virus Vaccine" (1 trials) and "GlaxoSmithKline Novel Influenza A H1N1 Split Virion Vaccine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Southampton National Institute for Health Research, Wellcome Trust Clinical Research Facility" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Southampton National Institute for Health Research, Wellcome Trust Clinical Research Facility". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 6 completed trials in Southampton National Institute for Health Research, Wellcome Trust Clinical Research Facility, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Southampton National Institute for Health Research, Wellcome Trust Clinical Research Facility, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".